P500-0686 Screening compound: 1'-ethyl-7'-fluoro-1-(3-methoxybenzoyl)-3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinazolin]-4'-one

P500-0686 Screening compound: 1'-ethyl-7'-fluoro-1-(3-methoxybenzoyl)-3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinazolin]-4'-one
P500-0686 Screening compound: 1'-ethyl-7'-fluoro-1-(3-methoxybenzoyl)-3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinazolin]-4'-one alternative view

Chemical Structure Depiction of ChemDiv screening compound P500-0686
1'-ethyl-7'-fluoro-1-(3-methoxybenzoyl)-3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinazolin]-4'-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P500-0686

Molecular Formula

C22H24FN3O3 (C22 H24 FN3 O3)

Compound Name

1'-ethyl-7'-fluoro-1-(3-methoxybenzoyl)-3',4'-dihydro-1'H-spiro[piperidine-4,2'-quinazolin]-4'-one

IUPAC name

1'-ethyl-7'-fluoro-1-(3-methoxybenzoyl)-3'4'-dihydro-1'H-spiro[piperidine-42'-quinazolin]-4'-one

SMILES

CCN(C(CC1)(CCN1C(c1cc(OC)ccc1)=O)N1)c(cc(cc2)F)c2C1=O

InChI

InChI=1S/C22H24FN3O3/c1-3-26-19-14-16(23)7-8-18(19)20(27)24-22(26)9-11-25(12-10-22)21(28)15-5-4-6-17(13-15)29-2/h4-8,13-14H,3,9-12H2,1-2H3,(H,24,27)

InChI Key

ACTKONRBYQDMJG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27576838

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

397.45

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.781

Distribution Coefficient, logD

2.781

Water Solubility, LogSw

-3.50

Polar Surface Area

51.142

Acid Dissociation Constant (pKa)

13.83

Base Dissociation Constant (pKb)

2.65

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.40

P500-0686 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P500-0686 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P500-0686?
Check Price and Availability of P500-0686, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P500-0686 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P500-0686
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P500-0686
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P500-0686 available by request